The short version of DAC linker fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-03-18 and is reviewed periodically as new material appears.
Identity and purity are established with reversed phase high performance liquid chromatography coupled to mass spectrometry. The chromatographic step separates the target peptide from truncated sequences and deletion products, while the mass measurement confirms the expected molecular weight to within a fraction of a dalton. Because the two common variants differ by the presence of the linker, mass alone can distinguish them in the unconjugated state. Amino acid analysis and peptide mapping are used when sequence level confirmation is required.
Lyophilized material is generally stable for extended periods when held at minus twenty degrees Celsius or below and protected from moisture and light. In solution the peptide is more labile; bond hydrolysis, aggregation and oxidation of susceptible residues all proceed faster at ambient temperature. Repeated freeze and thaw cycles should be avoided because they promote clumping and loss of soluble material. The conjugated variant adds a further consideration, since the maleimide group can hydrolyze in aqueous buffer and lose its ability to react with albumin.
Laboratory handling centers on minimizing exposure to water, heat and oxygen before use. Working solutions are typically prepared in sterile water or a mild buffer, and any residual particulate matter is removed by filtration. When the powder dissolves slowly, a small proportion of acetonitrile or dilute acetic acid is sometimes added as a co-solvent. Containers are kept sealed and desiccated between uses. Records of lot number, reconstitution date and storage conditions support later comparison of results across experiments.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off white powder | Typical lyophilized form |
| Water solubility | Soluble | May need a small organic co-solvent |
| Purity assessment | Chromatographic peak area | Most certificates report a percentage figure |
| Storage temperature | Minus 20 C or lower | Dry, dark, sealed container |
| Identity check | Electrospray mass spectrometry | Compared against theoretical mass |
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
As of 2016, NASA has published over 2,000 other spin-offs in the fields of computer technology, environment and agriculture, health and medicine, public safety, transportation, recreation, and industrial productivity. Contrary to common belief, NASA did not invent Tang, Velcro or Teflon.
== Background == During the early 19th century, a diverse group of Sotho-, Nguni- and Tswana-speaking tribes settled in the Caledon River region. The latter two, which formed the minority of the population, were gradually assimilated by the culturally dominant Sotho. King Moshoeshoe I united the various Sotho-speaking chieftainships into a single nation during a period of political turbulence known as Lifaqane. He transformed the denigratory exonym of Sotho into the name of the nascent Basuto nation. In 1833, missionaries from the Paris Evangelical Missionary Society began setting their outposts in Basuto lands following Moshoeshoe's invitation. They promoted a combination of Christianity, Western civilization, and commerce. They saw Basuto customs linked to obligatory labor and the dependence of the population on their chiefs as evil. They sought to undermine them by promoting private property, the commodization of production and closer economic ties with European settlers. In the 1820s, the Basuto faced cattle raids from the Koranna and first encountered horses and guns in a combat setting. They obtained horses and guns of their own, and began stockpiling gunpowder. By 1843, Moshoeshoe had accumulated more horses and guns than any other chieftain in South Africa, but the guns were outdated flintlocks, which had flooded the South African market after the introduction of percussion lock muskets.
=== Sweetpea Golightly === Sweetpea Golightly (Miriam Petche) is a new Pierpoint hire with TikTok and OnlyFans businesses on the side. She is revealed to have had an affair with Rishi, who subscribes to her OnlyFans page. Sweetpea is shown to be a shrewd and competent trader despite her seemingly carefree and social media-obsessed personality. She eventually discovers that a hefty debt Pierpoint issued five years ago to fund their pivot to ESG is reaching maturity, but cannot be paid off since the firm's ESG investments are not making any returns. She reports this to Eric, who tells her to keep it quiet; Harper later overhears Sweetpea telling Yasmin in the bathroom, and uses this information to plan a short of Pierpoint. After Pierpoint is sold to Al-Mi'raj Holdings, Sweetpea leaves the firm to go work for Harper. In series 4, Sweetpea works under Harper at Mostyn Asset Management, but is opposed to Harper's impulsive trading strategy. Sweetpea's explicit photos have leaked online, hurting her job prospects and straining her relationship with her mother. After Harper exits Mostyn's firm and starts her own fund with Eric called SternTao, she brings an apprehensive Sweetpea on board, and the two investigate the shady dealings of payment processing startup Tender, which Harper seeks to short. Sweetpea's investigation leads her on a trip to Accra alongside SternTao trader Kwabena Bannerman to uncover the truth behind Tender's business. Sweetpea is assaulted during the trip by a man possibly sent by Tender, and she and Kwabena have sex.
Significant increases in central MP levels were also observed after just two weeks of supplementation. Furthermore, in patients who had an atypical MP distribution in the eye (i.e., they did not have a high concentration of pigment in the centre of the macula), when supplemented with a meso-zeaxanthin-dominant supplement for 8 weeks, the normal pigment profile was reinstated, whereas this was not the case when patients were supplemented with a formulation lacking meso-zeaxanthin. The main findings from the MOST trials in patients with AMD were published in 2013 and 2015. The series of publications from these trials concluded, "Augmentation of the MP optical density across its spatial profile and enhancements in contrast sensitivity were best achieved after supplementation with a formulation containing high doses of meso-zeaxanthin in combination with lutein and zeaxanthin". Also, the final publication from this work, published in 2015, concluded that, "The inclusion of meso-zeaxanthin in a supplement formulation seems to confer benefits in terms of MP augmentation and in terms of enhanced contrast sensitivity in subjects with early AMD.". In 2016 and 2017, the results of two small clinical trials were published. The first trial, the CREST (Central Retinal Enrichment Supplementation Trials) study involved 105 normal healthy volunteers who underwent a series of complex tests of vision and were supplemented over 12 months.
Sources: en.wikipedia.org
Tennessee marble, extracted from quarries on the city's periphery, was used in the construction of numerous monumental buildings across the country, earning Knoxville the nickname, "The Marble City." Knoxville's economy slowed in the early 1900s. Political factioning hampered revitalization efforts throughout much of the 20th century, though the creation of federal entities such as the Tennessee Valley Authority in the 1930s and the ten-fold expansion of the University of Tennessee helped keep the economy stable. Beginning in the late 1960s, a city council more open to change, along with economic diversification, urban renewal, and the hosting of the 1982 World's Fair, helped the city revitalize to some extent.
Candida Histoplasmosis Dandruff Prion - Misfolded proteins that usually occur in the brain and trigger other normal proteins to misfold. They are extremely rare, and these built-up proteins lead to complications.
== Cosmetic use == Copper peptide GHK-Cu is widely used in anti-aging and hair loss prevention cosmetics (INCI name: Copper tripeptide-1). Several controlled facial studies have shown anti-aging, firming and anti-wrinkle activity of copper peptide GHK-Cu, but with relatively small sample sizes and short duration of use, and further research is required to draw definitive conclusions.
Sources: en.wikipedia.org
==== In venoms ==== Serotonin is a common component of invertebrate venoms, salivary glands, nervous tissues, and various other tissues, across molluscs, insects, crustaceans, scorpions, various kinds of worms, and jellyfish. Adult Rhodnius prolixus – hematophagous on vertebrates – secrete lipocalins into the wound during feeding. In 2003 these lipocalins were demonstrated to sequester serotonin to prevent vasoconstriction (and possibly coagulation) in the host.
=== 1920s === In 1928, British Scientist Alexander Fleming discovered the first antibiotic penicillin. This was a huge breakthrough in biomedical science because it allowed for the treatment of bacterial infections. In 1926, the first artificial pacemaker was made by Australian physician Dr. Mark C. Lidwell. This portable machine was plugged into a lighting point. One pole was applied to a skin pad soaked with strong salt solution, while the other consisted of a needle insulated up to the point and was plunged into the appropriate cardiac chamber and the machine started. A switch was incorporated to change the polarity. The pacemaker rate ranged from about 80 to 120 pulses per minute and the voltage also variable from 1.5 to 120 volts.
==== Metal ion peptide biosensors ==== Peptide sequence can serve as substitute for proteins in interacting with metallic ions since they share similar chemical structures. Certain peptide sequences exhibit high affinity for metal ions such as Zn²⁺, Cu²⁺, Pb²⁺, Hg²⁺, and Fe³⁺. This interaction can be utilized to design peptide-based sensors that can bind to metallic ions by conjugating the peptide sequence with signal markers
Sources: en.wikipedia.org
The mass difference from the linker is large enough for routine detection by mass spectrometry. The unconjugated form gives a single sharp signal at its expected weight. Material that has already reacted with albumin shows a much higher mass and a broadened chromatographic peak.
Yes. Degradation proceeds faster once the powder is dissolved, especially at room temperature or after multiple freeze and thaw cycles. Working solutions are often aliquoted to avoid repeated handling. Lyophilized powder held cold and dry retains its properties far longer.
Truncated sequences, oxidized residues and aggregated forms can all elute near the main peak. Reversed phase chromatography resolves many of these species, so the number of peaks is a useful indicator of synthesis quality. A single peak does not by itself prove correct sequence, which is why mass confirmation is paired with it.
A maleimide moiety reacts with the thiol of cysteine-34, forming a covalent bond. The reaction occurs in circulation without enzymatic catalysis.